Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy

Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD). The development and progression of DN might involve multiple factors. Connective tissue growth factor (CCN2, originally known as CTGF) is the one which plays a pivotal role. Therefore, increasing attention is being pai...

Full description

Saved in:
Bibliographic Details
Main Authors: Songyan Wang, Bing Li, Chunguang Li, Wenpeng Cui, Lining Miao
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2015/962383
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545965889814528
author Songyan Wang
Bing Li
Chunguang Li
Wenpeng Cui
Lining Miao
author_facet Songyan Wang
Bing Li
Chunguang Li
Wenpeng Cui
Lining Miao
author_sort Songyan Wang
collection DOAJ
description Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD). The development and progression of DN might involve multiple factors. Connective tissue growth factor (CCN2, originally known as CTGF) is the one which plays a pivotal role. Therefore, increasing attention is being paid to CCN2 as a potential therapeutic target for DN. Up to date, there are also many drugs or agents which have been shown for their protective effects against DN via different mechanisms. In this review, we only focus on the potential renoprotective therapeutic agents which can specifically abolish CCN2 expression or nonspecifically inhibit CCN2 expression for retarding the development and progression of DN.
format Article
id doaj-art-fe5ae91e51f74389abb5f90e07a3cded
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-fe5ae91e51f74389abb5f90e07a3cded2025-02-03T07:24:20ZengWileyJournal of Diabetes Research2314-67452314-67532015-01-01201510.1155/2015/962383962383Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic NephropathySongyan Wang0Bing Li1Chunguang Li2Wenpeng Cui3Lining Miao4Department of Nephrology, Second Hospital of Jilin University, Changchun 130041, ChinaDepartment of Nephrology, Jilin Province People’s Hospital, Changchun 130021, ChinaDepartment of Urology, The 2nd Hospital of Changchun, Changchun 130061, ChinaDepartment of Nephrology, Second Hospital of Jilin University, Changchun 130041, ChinaDepartment of Nephrology, Second Hospital of Jilin University, Changchun 130041, ChinaDiabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD). The development and progression of DN might involve multiple factors. Connective tissue growth factor (CCN2, originally known as CTGF) is the one which plays a pivotal role. Therefore, increasing attention is being paid to CCN2 as a potential therapeutic target for DN. Up to date, there are also many drugs or agents which have been shown for their protective effects against DN via different mechanisms. In this review, we only focus on the potential renoprotective therapeutic agents which can specifically abolish CCN2 expression or nonspecifically inhibit CCN2 expression for retarding the development and progression of DN.http://dx.doi.org/10.1155/2015/962383
spellingShingle Songyan Wang
Bing Li
Chunguang Li
Wenpeng Cui
Lining Miao
Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy
Journal of Diabetes Research
title Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy
title_full Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy
title_fullStr Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy
title_full_unstemmed Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy
title_short Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy
title_sort potential renoprotective agents through inhibiting ctgf ccn2 in diabetic nephropathy
url http://dx.doi.org/10.1155/2015/962383
work_keys_str_mv AT songyanwang potentialrenoprotectiveagentsthroughinhibitingctgfccn2indiabeticnephropathy
AT bingli potentialrenoprotectiveagentsthroughinhibitingctgfccn2indiabeticnephropathy
AT chunguangli potentialrenoprotectiveagentsthroughinhibitingctgfccn2indiabeticnephropathy
AT wenpengcui potentialrenoprotectiveagentsthroughinhibitingctgfccn2indiabeticnephropathy
AT liningmiao potentialrenoprotectiveagentsthroughinhibitingctgfccn2indiabeticnephropathy